Equities

IFR US ECM Calendar

| Robert Sherwood

April 1: Celldex Therapeutics (US, biotech) ─ $250m. ABB. Fixed size (Primary) marketed at $29.00-$29.50 versus $31.26 last sale. LEER, TDC. Wall cross.

Topics

Americas North America Canada Equity Capital ABBs and Block Trades Initial Public Offerings (IPO) Structured Equity Marketed Follow-Ons US Dollar United States

Issuers

Celldex Therapeutics Inc (CLDX.O)